Different Faces of Hepatocellular Carcinoma As a Health Threat in 21st Century

Overview

Journal Hepat Mon

Publisher Brieflands

Specialty Gastroenterology

Date 2013 Apr 25

PMID 23613688

Citations 4

Authors

Behzad Yeganeh

Mohammad Hashemi

Fredrick J de Serres

Marek J Los

Saeid Ghavami

Affiliations

Soon will be listed here.

Citing Articles

Efficacy and Safety of Transcatheter Arterial Chemoembolization and Transcatheter Arterial Chemotherapy Infusion in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Liu X, Wang Z, Chen Z, Liu L, Ma L, Dong L Oncol Res. 2017; 26(2):231-239.

PMID: 28911342 PMC: 7844720. DOI: 10.3727/096504017X15051752095738.

Assessment of Lipiodol Deposition and Residual Cancer for Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization via Iodine-Based Material Decomposition Images with Spectral Computed Tomography Imaging: A Preliminary Study.

Xu Y, Xiao A, Yang J, Zhang Z, Zhang G Iran J Radiol. 2015; 12(4):e26009.

PMID: 26715981 PMC: 4691528. DOI: 10.5812/iranjradiol.26009.

Pre-administration of turmeric prevents methotrexate-induced liver toxicity and oxidative stress.

Moghadam A, Tutunchi S, Namvaran-Abbas-Abad A, Yazdi M, Bonyadi F, Mohajeri D BMC Complement Altern Med. 2015; 15:246.

PMID: 26199067 PMC: 4511036. DOI: 10.1186/s12906-015-0773-6.

Long Noncoding RNAs in Interaction With RNA Binding Proteins in Hepatocellular Carcinoma.

Mohamadkhani A Hepat Mon. 2014; 14(5):e18794.

PMID: 24910706 PMC: 4030262. DOI: 10.5812/hepatmon.18794.

References

Konopnicki D, Mocroft A, de Wit S, Antunes F, Ledergerber B, Katlama C . Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS. 2005; 19(6):593-601. DOI: 10.1097/01.aids.0000163936.99401.fe. View

Hashemi M, Alavian S, Ghavami S, de Serres F, Salehi M, Doroudi T . High prevalence of alpha 1 antitrypsin phenotypes in viral hepatitis B infected patients in Iran. Hepatol Res. 2005; 33(4):292-7. DOI: 10.1016/j.hepres.2005.09.035. View

Yeh M . Pathology of combined hepatocellular-cholangiocarcinoma. J Gastroenterol Hepatol. 2010; 25(9):1485-92. DOI: 10.1111/j.1440-1746.2010.06430.x. View

Ng J, Wu J . Hepatitis B- and hepatitis C-related hepatocellular carcinomas in the United States: similarities and differences. Hepat Mon. 2012; 12(10 HCC):e7635. PMC: 3517810. DOI: 10.5812/hepatmon.7635. View

Dai H, Liu L, Qin S, He X, Li S . Lobaplatin suppresses proliferation and induces apoptosis in the human colorectal carcinoma cell Line LOVO in vitro. Biomed Pharmacother. 2011; 65(3):137-41. DOI: 10.1016/j.biopha.2010.12.001. View

Llovet J, Bruix J . Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol. 2008; 48 Suppl 1:S20-37. DOI: 10.1016/j.jhep.2008.01.022. View

Blanco I, de Serres F, Carcaba V, Lara B, Fernandez-Bustillo E . Alpha-1 Antitrypsin Deficiency PI*Z and PI*S Gene Frequency Distribution Using on Maps of the World by an Inverse Distance Weighting (IDW) Multivariate Interpolation Method. Hepat Mon. 2012; 12(10 HCC):e7434. PMC: 3500828. DOI: 10.5812/hepatmon.7434. View

Du Y, Su T, Ding Y, Cao G . Effects of antiviral therapy on the recurrence of hepatocellular carcinoma after curative resection or liver transplantation. Hepat Mon. 2012; 12(10 HCC):e6031. PMC: 3500771. DOI: 10.5812/hepatmon.6031. View

Sternberg C, De Mulder P, Fossa S, Kaye S, Roberts T, Pawinsky A . Lobaplatin in advanced urothelial tract tumors. The Genitourinary Group of the European Organization for Research and Treatment of Cancer (EORTC). Ann Oncol. 1997; 8(7):695-6. DOI: 10.1023/a:1008269432176. View

10.

Gietema J, Guchelaar H, De Vries E, Aulenbacher P, Sleijfer D, Mulder N . A phase I study of lobaplatin (D-19466) administered by 72 h continuous infusion. Anticancer Drugs. 1993; 4(1):51-5. DOI: 10.1097/00001813-199302000-00007. View

11.

Rodriguez-Mendez M, Gonzalez-Quintela A, Aguilera A, Barrio E . Prevalence, patterns, and course of past hepatitis B virus infection in intravenous drug users with HIV-1 infection. Am J Gastroenterol. 2000; 95(5):1316-22. DOI: 10.1111/j.1572-0241.2000.01981.x. View

12.

Hussain S, Schwank J, Staib F, Wang X, Harris C . TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Oncogene. 2007; 26(15):2166-76. DOI: 10.1038/sj.onc.1210279. View

13.

Lacombe K, Rockstroh J . HIV and viral hepatitis coinfections: advances and challenges. Gut. 2012; 61 Suppl 1:i47-58. DOI: 10.1136/gutjnl-2012-302062. View

14.

Maletzki C, Bodammer P, Breitruck A, Kerkhoff C . S100 proteins as diagnostic and prognostic markers in colorectal and hepatocellular carcinoma. Hepat Mon. 2012; 12(10 HCC):e7240. PMC: 3500829. DOI: 10.5812/hepatmon.7240. View

15.

de Serres F, Blanco I, Fernandez-Bustillo E . Genetic epidemiology of alpha-1 antitrypsin deficiency in southern Europe: France, Italy, Portugal and Spain. Clin Genet. 2003; 63(6):490-509. DOI: 10.1034/j.1399-0004.2003.00078.x. View

16.

Zidan A, Scheuerlein H, Schule S, Settmacher U, Rauchfuss F . Epidemiological pattern of hepatitis B and hepatitis C as etiological agents for hepatocellular carcinoma in iran and worldwide. Hepat Mon. 2012; 12(10 HCC):e6894. PMC: 3517809. DOI: 10.5812/hepatmon.6894. View

17.

Halayko A, Ghavami S . S100A8/A9: a mediator of severe asthma pathogenesis and morbidity?. Can J Physiol Pharmacol. 2009; 87(10):743-55. DOI: 10.1139/Y09-054. View

18.

Topic A, Ljujic M, Radojkovic D . Alpha-1-antitrypsin in pathogenesis of hepatocellular carcinoma. Hepat Mon. 2012; 12(10 HCC):e7042. PMC: 3496874. DOI: 10.5812/hepatmon.7042. View

19.

Sinha P, Okoro C, Foell D, Freeze H, Ostrand-Rosenberg S, Srikrishna G . Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells. J Immunol. 2008; 181(7):4666-75. PMC: 2810501. DOI: 10.4049/jimmunol.181.7.4666. View

20.

Alter M . Epidemiology of viral hepatitis and HIV co-infection. J Hepatol. 2005; 44(1 Suppl):S6-9. DOI: 10.1016/j.jhep.2005.11.004. View